Category: Johnson & JohnsonSyndicate content

Report: J&J puts Cordis on the block

August 29, 2014 by Arezu Sarvestani

Johnson & Johnson puts its Cordis vascular device business on the auction block after years of sluggish growth.

Report: J&J's selling its Cordis division

Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company's stents, catheters and other vascular devices, according to a report from the Wall Street Journal.

DePuy Synthes gets FDA's highest-risk warning after 15 complaints

August 27, 2014 by Arezu Sarvestani

The FDA puts its highest-risk Class I label on the recall of DePuy Synthes' jaw stabilizing system over a defect that may result in injury or death in infants.

DePuy Synthes recalls orthopedic implant, gets FDA's highest-risk warning

FDA regulators put their highest-risk Class I label on the recall of DePuy Synthes' Craniomaxillofacial Distraction System after the company reported 15 injuries associated with the jaw implant.

Judge agrees to toss ex-Biosense rep's suit in non-compete row with St. Jude Medical

August 27, 2014 by Brad Perriello

A federal judge agrees to toss a lawsuit filed against Johnson & Johnson's Biosense Webster by a former sales rep and her new employer, St. Jude Medical.

Judge agrees to toss ex-Biosense rep's suit in non-compete row with St. Jude Medical

Report: Schumer, Gillibrand want morcellators off the market

August 19, 2014 by Brad Perriello

Sens. Chuck Schumer and Kristen Gillibrand plan to ask the FDA to push medical device companies to pull power morcellators off the U.S. market, after the hysterectomy devices were implicated in spreading uterine cancers.

Report: Schumer, Gillibrand want morcellators off the market

The U.S. Senate delegation from New York want to see power morcellators, which have been linked to the spread of undiagnosed uterine cancer, pulled from the U.S. market, the Wall Street Journal reported last night.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

COV shareholder sues to block pending MDT merger | Medtech legal news for the week of August 18, 2014

August 18, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Another Covidien shareholder sues to block Medtronic merger; Ex-Integra sales rep, manager cop to $800k hospital fraud scheme; Diabetes: Medtronic, Johnson & Johnson settle patent spat; Stryker settles hip implant suit against J&J's DePuy; Appeals court reverses Medtronic's win in Lenox bone mill spat

Another Covidien shareholder sues to block Medtronic merger

August 12, 2014 by Brad Perriello

Stryker settles hip implant suit against J&J's DePuy

August 13, 2014 by Brad Perriello

Stryker Corp. settles a patent infringement lawsuit filed against Johnson & Johnson's DePuy Orthopaedics division; co-defendants Wright Medical, Zimmer Holdings and Smith & Nephew move to have their cases tossed as well.

Stryker settles hip implant suit against J&J's DePuy

Diabetes: Medtronic, Johnson & Johnson settle patent spat

August 13, 2014 by Brad Perriello

Medtronic and Johnson & Johnson agree to a confidential settlement of a patent infringement lawsuit brought by Medtronic MiniMed against J&J's Animas division.

Medtronic, Johnson & Johnson settle diabetes patent spat

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp